| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.791 | 5.766 | 11.789 | 19.550 | 24.675 | 23.666 | 24.283 | 39.073 | 69.378 | 77.580 |
| Total Income - EUR | 4.791 | 5.766 | 11.789 | 19.594 | 24.675 | 23.666 | 24.283 | 39.073 | 69.378 | 77.580 |
| Total Expenses - EUR | 4.451 | 3.160 | 5.030 | 6.061 | 4.048 | 3.741 | 3.254 | 25.241 | 39.170 | 38.478 |
| Gross Profit/Loss - EUR | 341 | 2.606 | 6.758 | 13.533 | 20.627 | 19.925 | 21.029 | 13.832 | 30.209 | 39.102 |
| Net Profit/Loss - EUR | 197 | 2.433 | 6.405 | 12.946 | 19.999 | 19.399 | 20.446 | 13.381 | 29.706 | 36.821 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Endora Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 175 | 173 | 170 | 831 | 509 | 1.100 | 324 | 70.696 | 60.252 | 47.937 |
| Current Assets | 622 | 3.088 | 8.628 | 12.304 | 26.204 | 24.904 | 26.365 | 13.188 | 44.843 | 60.243 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 186 | 75 | 312 | 275 | 3.920 | 2.395 | 1.195 | 3.138 | 36.601 | 47.257 |
| Cash | 436 | 3.013 | 8.316 | 12.029 | 22.283 | 22.509 | 25.170 | 10.050 | 8.242 | 12.985 |
| Shareholders Funds | -107 | 2.327 | 8.692 | 12.997 | 26.579 | 25.854 | 26.542 | 40.005 | 69.590 | 78.883 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 903 | 934 | 105 | 138 | 134 | 150 | 147 | 43.878 | 35.506 | 29.297 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Endora Med Srl